[Form 4] CoreWeave, Inc. Insider Trading Activity

Rhea-AI Filing Summary

CoreWeave insider sales under 10b5-1 plan: The filing shows that McBee Brannin, CoreWeave (CRWV) Chief Development Officer, sold a total of 625,000 shares of Class A common stock on 09/09/2025 under a Rule 10b5-1 trading plan adopted May 20, 2025. Sales were executed in multiple transactions at weighted-average prices ranging roughly between $97.14 and $103.20. The report discloses both directly held shares and shares held indirectly through the Brannin J. McBee 2022 Irrevocable Trust and the Canis Major SM Trust, with remaining beneficial ownership reported on the form.

Positive

• Sales were executed under a Rule 10b5-1 trading plan, indicating pre-established instructions adopted May 20, 2025
• Full disclosure of indirect holdings via the Brannin J. McBee 2022 Irrevocable Trust and Canis Major SM Trust, including trustee details
• Weighted-average prices and ranges for each lot are provided, enhancing transaction transparency

Negative

• Substantial disposals totaling 625,000 shares on 09/09/2025, which materially reduce reported beneficial ownership
• Large sale sizes across multiple price bands ($97.14 to $103.20) could be perceived as noteworthy by investors absent further context

Insights

Financial Analyst

TL;DR: Insider executed pre-established 10b5-1 sales totaling 625,000 shares; neutral signal without additional context on timing.

The filing documents systematic dispositions under a Rule 10b5-1 plan, indicating the sales were pre-planned rather than opportunistic trades. The aggregate sale size of 625,000 shares is material in absolute terms and reduces the reporting persons direct and indirect holdings as disclosed. Without market-cap or ownership percent in the filing, the market impact and change in ownership stake cannot be assessed from this document alone.

Corporate Governance Expert

TL;DR: Proper disclosure and use of 10b5-1 plan shown; trusts and trustee arrangements are clearly reported.

The Form 4 provides required detail on indirect holdings via an irrevocable trust and a minors account and notes the reporting persons spouse and child as trust beneficiaries. Signatures include an attorney-in-fact, and explanations identify weighted-average prices and transaction ranges. The report follows Section 16 disclosure conventions and clarifies trustee control for the Canis Major SM Trust.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McBee Brannin

(Last) (First) (Middle)

C/O COREWEAVE, INC.

290 WEST MT. PLEASANT AVENUE, SUITE 4100

(Street)

LIVINGSTON NJ 07039

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CoreWeave, Inc. [ CRWV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Development Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/09/2025		S(1)		53,735	D	$97.7829(2)	318,230	D
Class A Common Stock	09/09/2025		S(1)		76,005	D	$98.5753(3)	242,225	D
Class A Common Stock	09/09/2025		S(1)		22,002	D	$99.7547(4)	220,223	D
Class A Common Stock	09/09/2025		S(1)		61,683	D	$100.5975(5)	158,540	D
Class A Common Stock	09/09/2025		S(1)		30,875	D	$101.5445(6)	127,665	D
Class A Common Stock	09/09/2025		S(1)		5,500	D	$102.6273(7)	122,165	D
Class A Common Stock	09/09/2025		S(1)		200	D	$103.19(8)	121,965	D
Class A Common Stock	09/09/2025		S(1)		83,883	D	$97.7949(9)	291,117	I	Brannin J. McBee 2022 Irrevocable Trust(10)
Class A Common Stock	09/09/2025		S(1)		112,622	D	$98.5974(11)	178,495	I	Brannin J. McBee 2022 Irrevocable Trust(10)
Class A Common Stock	09/09/2025		S(1)		29,600	D	$99.7875(12)	148,895	I	Brannin J. McBee 2022 Irrevocable Trust(10)
Class A Common Stock	09/09/2025		S(1)		95,522	D	$100.6011(13)	53,373	I	Brannin J. McBee 2022 Irrevocable Trust(10)
Class A Common Stock	09/09/2025		S(1)		44,873	D	$101.5703(14)	8,500	I	Brannin J. McBee 2022 Irrevocable Trust(10)
Class A Common Stock	09/09/2025		S(1)		8,400	D	$102.6506(15)	100	I	Brannin J. McBee 2022 Irrevocable Trust(10)
Class A Common Stock	09/09/2025		S(1)		100	D	$103.2	0	I	Brannin J. McBee 2022 Irrevocable Trust(10)
Class A Common Stock								60,000	I	Canis Major SM Trust(16)
Class A Common Stock								1,800	I	See Footnote(17)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2025.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.14 to $98.13, inclusive.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.14 to $99.12, inclusive.

4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.17 to $100.16, inclusive.

5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.17 to $101.16, inclusive.

6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.17 to $102.15, inclusive.

7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.17 to $103.04, inclusive.

8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.18 to $103.20, inclusive.

9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.16 to $98.155, inclusive.

10. The reported securities are directly held by the Brannin J. McBee 2022 Irrevocable Trust, of which the reporting person's spouse and minor child are beneficiaries and for which the reporting person's spouse serves as trustee.

11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.16 to $99.15, inclusive.

12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.16 to $100.15, inclusive.

13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.18 to $101.17, inclusive.

14. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.18 to $102.17, inclusive.

15. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.20 to $103.04, inclusive.

16. The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee.

17. The reported securities are directly held of record by the reporting person's minor child.

	/s/ Kristen McVeety, as Attorney-in-Fact	09/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did CoreWeave (CRWV) insider McBee Brannin sell on 09/09/2025?

The filing reports that McBee Brannin sold a total of 625,000 Class A shares on 09/09/2025 in multiple transactions under a Rule 10b5-1 plan.

Were the sales part of a pre-established plan?

Yes. The report states the sales were effected pursuant to a 10b5-1 trading plan adopted May 20, 2025.

At what prices were the shares sold?

Reported weighted-average prices for the various lots range roughly from $97.14 to $103.20, with detailed ranges provided for each sale lot in the filing.

Did the filing disclose indirect ownership or trusts?

Yes. Shares are held directly and indirectly, including the Brannin J. McBee 2022 Irrevocable Trust and the Canis Major SM Trust, with trustee and beneficiary relationships disclosed.

Who signed the Form 4 and when?

The form is signed by /s/ Kristen McVeety, as Attorney-in-Fact with the date 09/11/2025.